• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Migraine Headache - Myth vs Facts

Slideshow

There is a good deal of misinformation available about migraine headaches. Which of these 10 statements are myth and which are fact?

  

Recent Videos
Primary Care is the Answer to the Migraine Care Gap, Says Headache Specialist
Migraine Management Pearls for Primary Care with Neurologist Jessica Ailani, MD
Migraine-specific therapies belong in primary care setting, Jessica Ailani, MD
Related Content
Atogepant Improves QoL, Function in Adults with Chronic, Episodic, Treatment-Resistant Migraine / image credit Christopher Gottschalk, MD courtesy of Yale Medicine

Atogepant Improves QoL, Function in Adults with Chronic, Episodic, Treatment-Resistant Migraine

Grace Halsey
December 10th 2024
Article

An analysis of patient reported outcome measures from 3 pivotal phase 3 RCTs of atogepant 60 mg demonstrates efficacy across functional domains as well as for migraine prevention.

Gepants for Migraine Prevention: A Perfect Fit for Primary Care

Gepants for Migraine Prevention: A Perfect Fit for Primary Care

Sydney Jennings
March 30th 2022
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with headache specialist Peter McAllister, MD.

Novel DHE Nasal Spray for Acute Treatment of Migraine: Daily Dose / image credit: ©New Africa/AdobeStock

Novel DHE Nasal Spray for Acute Treatment of Migraine: Daily Dose

Sydney Jennings
October 29th 2024
Article

Your daily dose of the clinical news you may have missed.

Primary Viewpoints Episode 1: COVID-19 Impact on Migraine Management

Primary Viewpoints Episode 1: COVID-19 Impact on Migraine Management

Sydney Jennings
July 20th 2020
Podcast

In episode 1 of Primary Viewpoints, migraine specialist Peter McAllister, MD, discusses how the COVID-19 pandemic has impacted his migraine patients.

Novel DHE Nasal Spray Safe, Effective For Acute Treatment of Migraine in Long-Term Safety Trial / image credit migraine concept: ©Mobic/Shutterstock.com

Novel DHE Nasal Spray Safe, Effective For Acute Treatment of Migraine in Long-Term Safety Trial

Grace Halsey
October 15th 2024
Article

Use of the unique STS101 drug device combination proved safe, well tolerated, and effective with as needed use over 12 months, reported Satsuma Pharmaceuticals.

Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine: Daily Dose / image credit: ©New Africa/AdobeStock

Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine: Daily Dose

Sydney Jennings
October 3rd 2024
Article

Your daily dose of the clinical news you may have missed.

© 2024 MJH Life Sciences

All rights reserved.